{
    "ABCC5": {
        "expression": [
            {
                "Organ": "Brain",
                "Source": "Nishimura",
                "Relative Expression": "0.0484"
            },
            {
                "Organ": "Kidney*",
                "Source": "Nishimura",
                "Relative Expression": "0.0193"
            },
            {
                "Organ": "Liver",
                "Source": "Nishimura",
                "Relative Expression": "0.00500"
            },
            {
                "Organ": "Placenta*",
                "Source": "Nishimura",
                "Relative Expression": "0.00803"
            },
            {
                "Organ": "Small Intestine",
                "Source": "Nishimura",
                "Relative Expression": "0.00820"
            },
            {
                "Organ": "Kidney*",
                "Source": "Mean across all PMT Samples",
                "Relative Expression": "10.428"
            },
            {
                "Organ": "Liver",
                "Source": "Mean across all PMT Samples",
                "Relative Expression": "BLQ"
            }
        ],
        "inhibitors": [
            {
                "Inhibitor": "5-fluorodeoxyuridine monophosphate",
                "IC50 (μM)": null,
                "Ki (μM)": 1163.0,
                "Substrate used": "Carboxydichlorofluorescein",
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2006"
            },
            {
                "Inhibitor": "5-nitro-2-(3-phenylpropylamino)-benzoic acid (NPPB)",
                "IC50 (μM)": 2.0,
                "Ki (μM)": null,
                "Substrate used": "5-fluorodeoxyuridine monophosphate",
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2005"
            },
            {
                "Inhibitor": "5-nitro-2-(3-phenylpropylamino)-benzoic acid (NPPB)",
                "IC50 (μM)": 0.102,
                "Ki (μM)": null,
                "Substrate used": "Carboxydichlorofluorescein",
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2006"
            },
            {
                "Inhibitor": "Benzbromarone",
                "IC50 (μM)": 150.0,
                "Ki (μM)": null,
                "Substrate used": "9-(2-phosphonomethoxyethyl)adenine (PMEA)",
                "Cell System": "MRP4-expressing HEK293 vesicles",
                "Reference": "Reid, 2003"
            },
            {
                "Inhibitor": "Cyclic GMP",
                "IC50 (μM)": 960.0,
                "Ki (μM)": null,
                "Substrate used": "5-fluorodeoxyuridine monophosphate",
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2005"
            },
            {
                "Inhibitor": "Cyclic GMP",
                "IC50 (μM)": 4855.5,
                "Ki (μM)": null,
                "Substrate used": "Carboxydichlorofluorescein",
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2006"
            },
            {
                "Inhibitor": "Dipyridamole",
                "IC50 (μM)": 30.0,
                "Ki (μM)": null,
                "Substrate used": "9-(2-phosphonomethoxyethyl)adenine (PMEA)",
                "Cell System": "MRP4-expressing HEK293 vesicles",
                "Reference": "Reid, 2003"
            },
            {
                "Inhibitor": "Glyburide",
                "IC50 (μM)": 15.0,
                "Ki (μM)": null,
                "Substrate used": "5-fluorodeoxyuridine monophosphate",
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2005"
            },
            {
                "Inhibitor": "Methotrexate",
                "IC50 (μM)": 780.0,
                "Ki (μM)": null,
                "Substrate used": "5-fluorodeoxyuridine monophosphate",
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2005"
            },
            {
                "Inhibitor": "Methotrexate",
                "IC50 (μM)": null,
                "Ki (μM)": 1059.0,
                "Substrate used": "Carboxydichlorofluorescein",
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2006"
            },
            {
                "Inhibitor": "MK-571",
                "IC50 (μM)": 17.0,
                "Ki (μM)": null,
                "Substrate used": "5-fluorodeoxyuridine monophosphate",
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2005"
            },
            {
                "Inhibitor": "MK-571",
                "IC50 (μM)": 200.0,
                "Ki (μM)": null,
                "Substrate used": "9-(2-phosphonomethoxyethyl)adenine (PMEA)",
                "Cell System": "MRP4-expressing HEK293 vesicles",
                "Reference": "Reid, 2003"
            },
            {
                "Inhibitor": "MK-571",
                "IC50 (μM)": 15.9,
                "Ki (μM)": null,
                "Substrate used": "Carboxydichlorofluorescein",
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2006"
            },
            {
                "Inhibitor": "Pemetrexed",
                "IC50 (μM)": 2110.0,
                "Ki (μM)": null,
                "Substrate used": "5-fluorodeoxyuridine monophosphate",
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2005"
            },
            {
                "Inhibitor": "Pemetrexed",
                "IC50 (μM)": 442.0,
                "Ki (μM)": null,
                "Substrate used": "Carboxydichlorofluorescein",
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2006"
            },
            {
                "Inhibitor": "Pemetrexed",
                "IC50 (μM)": null,
                "Ki (μM)": 300.0,
                "Substrate used": "Carboxydichlorofluorescein",
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2006"
            },
            {
                "Inhibitor": "Probenecid",
                "IC50 (μM)": 70.0,
                "Ki (μM)": null,
                "Substrate used": "5-fluorodeoxyuridine monophosphate",
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2005"
            },
            {
                "Inhibitor": "Probenecid",
                "IC50 (μM)": 200.0,
                "Ki (μM)": null,
                "Substrate used": "9-(2-phosphonomethoxyethyl)adenine (PMEA)",
                "Cell System": "MRP4-expressing HEK293 vesicles",
                "Reference": "Reid, 2003"
            },
            {
                "Inhibitor": "Probenecid",
                "IC50 (μM)": 34.0,
                "Ki (μM)": null,
                "Substrate used": "Carboxydichlorofluorescein",
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2006"
            },
            {
                "Inhibitor": "Sildenafil",
                "IC50 (μM)": 580.0,
                "Ki (μM)": null,
                "Substrate used": "5-fluorodeoxyuridine monophosphate",
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2005"
            },
            {
                "Inhibitor": "Sildenafil",
                "IC50 (μM)": 80.0,
                "Ki (μM)": null,
                "Substrate used": "9-(2-phosphonomethoxyethyl)adenine (PMEA)",
                "Cell System": "MRP4-expressing HEK293 vesicles",
                "Reference": "Reid, 2003"
            },
            {
                "Inhibitor": "Sildenafil",
                "IC50 (μM)": null,
                "Ki (μM)": 0.267,
                "Substrate used": "Cyclic GMP",
                "Cell System": "MRP5-expressing V79 vesicles",
                "Reference": "Jedlitschky, 2000"
            },
            {
                "Inhibitor": "Sulfinpyrazone",
                "IC50 (μM)": 300.0,
                "Ki (μM)": null,
                "Substrate used": "9-(2-phosphonomethoxyethyl)adenine (PMEA)",
                "Cell System": "MRP4-expressing HEK293 vesicles",
                "Reference": "Reid, 2003"
            },
            {
                "Inhibitor": "Sulfinpyrazone",
                "IC50 (μM)": 103.2,
                "Ki (μM)": null,
                "Substrate used": "Carboxydichlorofluorescein",
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2006"
            },
            {
                "Inhibitor": "Trequinsin",
                "IC50 (μM)": 580.0,
                "Ki (μM)": null,
                "Substrate used": "5-fluorodeoxyuridine monophosphate",
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2005"
            },
            {
                "Inhibitor": "Trequinsin",
                "IC50 (μM)": 30.0,
                "Ki (μM)": null,
                "Substrate used": "9-(2-phosphonomethoxyethyl)adenine (PMEA)",
                "Cell System": "MRP4-expressing HEK293 vesicles",
                "Reference": "Reid, 2003"
            },
            {
                "Inhibitor": "Trequinsin",
                "IC50 (μM)": 218.0,
                "Ki (μM)": null,
                "Substrate used": "Carboxydichlorofluorescein",
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2006"
            },
            {
                "Inhibitor": "Trequinsin",
                "IC50 (μM)": null,
                "Ki (μM)": 0.24,
                "Substrate used": "Cyclic GMP",
                "Cell System": "MRP5-expressing V79 vesicles",
                "Reference": "Jedlitschky, 2000"
            },
            {
                "Inhibitor": "Zaprinast",
                "IC50 (μM)": 20.0,
                "Ki (μM)": null,
                "Substrate used": "5-fluorodeoxyuridine monophosphate",
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2005"
            },
            {
                "Inhibitor": "Zaprinast",
                "IC50 (μM)": 250.0,
                "Ki (μM)": null,
                "Substrate used": "9-(2-phosphonomethoxyethyl)adenine (PMEA)",
                "Cell System": "MRP4-expressing HEK293 vesicles",
                "Reference": "Reid, 2003"
            },
            {
                "Inhibitor": "Zaprinast",
                "IC50 (μM)": 32.3,
                "Ki (μM)": null,
                "Substrate used": "Carboxydichlorofluorescein",
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2006"
            }
        ],
        "substrates": [
            {
                "Substrate": "5-fluorodeoxyuridine monophosphate",
                "Km (μM)": 1100.0,
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2005"
            },
            {
                "Substrate": "5-fluorodeoxyuridine monophosphate",
                "Km (μM)": 1100.0,
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2006"
            },
            {
                "Substrate": "Carboxydichlorofluorescein",
                "Km (μM)": 11.6,
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2006"
            },
            {
                "Substrate": "Cyclic AMP",
                "Km (μM)": 379.0,
                "Cell System": "MRP5-expressing V79 vesicles",
                "Reference": "Jedlitschky, 2000"
            },
            {
                "Substrate": "Cyclic GMP",
                "Km (μM)": 2.1,
                "Cell System": "MRP5-expressing V79 vesicles",
                "Reference": "Jedlitschky, 2000"
            },
            {
                "Substrate": "Folic acid",
                "Km (μM)": 1000.0,
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Wielinga, 2005"
            },
            {
                "Substrate": "Methotrexate",
                "Km (μM)": 1174.0,
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2006"
            },
            {
                "Substrate": "Methotrexate",
                "Km (μM)": 1200.0,
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Wielinga, 2005"
            },
            {
                "Substrate": "Methotrexate-glucuronide",
                "Km (μM)": 700.0,
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Wielinga, 2005"
            },
            {
                "Substrate": "Pemetrexed",
                "Km (μM)": 281.0,
                "Cell System": "MRP5-expressing HEK293 vesicles",
                "Reference": "Pratt, 2006"
            }
        ],
        "ddi": [
            {
                "DDI": "1",
                "Implicated Transporter": "MRPs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Cefmetazole",
                "AUC": "1.6",
                "Cmax": "NS",
                "CLR": "0.6",
                "CL/F": "0.6",
                "t1/2": "1.5",
                "Effect on PD": "ND",
                "Reference": "Ko, 1989",
                "More Details": "DDI 1"
            },
            {
                "DDI": "2",
                "Implicated Transporter": "OATs/MRPs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Ciprofloxacin",
                "AUC": "1.7",
                "Cmax": "NS",
                "CLR": "0.4",
                "CL/F": "0.6",
                "t1/2": "1.5",
                "Effect on PD": "ND",
                "Reference": "Jaehde, 1995",
                "More Details": "DDI 2"
            },
            {
                "DDI": "3",
                "Implicated Transporter": "OATs/MRPs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Furosemide",
                "AUC": "2.7",
                "Cmax": "1.5",
                "CLR": "0.3",
                "CL/F": "0.4",
                "t1/2": "1.7",
                "Effect on PD": "ND",
                "Reference": "Vree, 1995",
                "More Details": "DDI 3"
            }
        ]
    }
}